Alain Vicari

10.2k citations

56 papers · 8.3k indexed · 2 hit papers · h-index 35

Impact in

Immunology top 0.2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immune cells in cancer
- interferon and immune responses
Oncology top 1%
- Chemokine receptors and signaling
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 47
- Immunotherapy and Immune Responses 31
- T-cell and B-cell Immunology 28
- Immune Cell Function and Interaction 18
- Immune Response and Inflammation 15
Oncology 25
- Chemokine receptors and signaling 15
- CAR-T cell therapy research 4

Co-authors: Christophe Caux Albert Zlotnik Giorgio Trinchieri Smina Aït‐Yahia Marie‐Caroline Dieu‐Nosjean Anne O’Garra Serge Lebecque Francine Brière
Journals: The Journal of Immunology (7 papers)The Journal of Experimental Medicine (5 papers)International Immunology (4 papers)Proceedings of the National Academy of Sciences (3 papers)European Journal of Immunology (3 papers)
Partner nations: United States France Canada

In The Last Decade

Alain Vicari

55 papers receiving 8.1k citations

Hit Papers

align trajectories log scale

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology 2001 · 814 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2001 Nature Immunology
1998 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Alain Vicari

Since Specialization

Citations

This map shows the geographic impact of Alain Vicari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Vicari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Vicari more than expected).

Fields of papers citing papers by Alain Vicari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Vicari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Vicari. The network helps show where Alain Vicari may publish in the future.

Co-authors

The 25 scholars most cited alongside Alain Vicari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alain Vicari Line = papers co-authored together Alain Vicari links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	789 CALY-002, AN ANTI-IL-15 ANTIBODY, PREVENTS GLUTEN CHALLENGEINDUCED MUCOSAL DAMAGE AND INFLAMMATION: RESULTS FROM A PHASE 1A/B STUDY Gastroenterology ·Michael Schümann, J. G. A. Houbiers, Yolande Chvatchko, Markku Mäki, Knut E. A. Lundin, Detlef Schuppan, Tim Vanuytsel, Yurdagül Zopf, Pierre H. Deprez, Peter Hasselblatt, Juha Taavela, 汪锡孝, Peter J. Wahab, Jorma Isola, Chiara Citterio, Andreana Laurencia, Josefin-Beate Holz, Alain Vicari, Gerd Bouma	2024	3
2	La mystérieuse Œsophagite à Eosinophiles garde encore quelques secrets HEGEL - HEpato-GastroEntérologie Libérale ·Alain Vicari	2017	0
3	pre-clinical Proof-of-concept Of Alx-0761, a Nanobody® Neutralizing Both Il-17a and F In a Cynomolgus Monkey Collagen Induced Arthritis Model. : 1287 Arthritis & Rheumatism ·Marika Lemos, Laurent Detalle, Alex Hemeryck, Alain Vicari, Roland Grenningloh, Sofie Poelmans, Heidi Wouters, Thomas Stöhr	2013	10
4	Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses The Journal of Immunology ·Alexandra Forsbach, Mao Ye, А.Г. Тархнишвли, Christian Müller, Ulrike Samulowitz, Alain Vicari, Marion Jurk, George Mutwiri, Arthur Μ. Krieg, Grayson B. Lipford, Jürgen Vollmer	2008	248
5	Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse Cancer Immunology Immunotherapy ·Alain Vicari, Maria Toledo, Ningli Zhang, Kalpana Palanisamy, Edwin Villalpando, Douglas C. Hanson, Risini D. Weeratna, Arthur Μ. Krieg	2008	100
6	Dendritic Cells Rapidly Recruited into Epithelial Tissues via CCR6/CCL20 Are Responsible for CD8+ T Cell Crosspriming In Vivo Immunity ·Marie Le Borgne, Nathalie Etchart, Anne Goubier, Sérgio A. Lira, Jean‐Claude Sirard, Nico van Rooijen, Christophe Caux, Smina Aït‐Yahia, Alain Vicari, Dominique Kaiserlian, Bertrand Dubois	2006	314
7	Redirecting In vivo Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection Cancer Research ·Cristiana Guiducci, Alain Vicari, Sabina Sangaletti, Giorgio Trinchieri, Mario P. Colombo	2005	436
8	MyD88-Dependent and -Independent Murine Cytomegalovirus Sensing for IFN-α Release and Initiation of Immune Responses In Vivo The Journal of Immunology ·Thomas Delale, André Paquin, Carine Asselin‐Paturel, Marc Dalod, Géraldine Brizard, Elizabeth E. M. Bates, Philippe Kastner, Susan Chan, Shizuo Akira, Alain Vicari, Christine A. Biron, Giorgio Trinchieri, Francine Brière	2005	163
9	In vivo Manipulation of Dendritic Cell Migration and Activation to Elicit Antitumour Immunity Novartis Foundation symposium ·Alain Vicari, Béatrice Vanbervliet, Catherine Massacrier, Claudia Chiodoni, J. Lionel Bennett, Smina Aït‐Yahia, Christophe Dercamp, 黒木修一, Olivier Reynard, Mohammed Saleh, Philippe Merle, Mario P. Colombo, Anne O’Garra, Giorgio Trinchieri, Christophe Caux	2004	27
10	What's new in the field of cancer vaccines? Cellular and Molecular Life Sciences ·Toufic Renno, Nathalie Renard, Sem Saeland, Alain Vicari	2003	18
11	Tumour escape from immune surveillance through dendritic cell inactivation Seminars in Cancer Biology ·Alain Vicari, Christophe Caux, Giorgio Trinchieri	2002	191
12	Chemokines in cancer Cytokine & Growth Factor Reviews ·Alain Vicari, Christophe Caux	2002	277
13	Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces European Journal of Immunology ·Béatrice Vanbervliet, Bernhard Homey, Isabelle Durand, Catherine Massacrier, Smina Aït‐Yahia, Odette de Bouteiller, Alain Vicari, Christophe Caux	2002	132
14	Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology Nature Immunology ·Carine Asselin‐Paturel, André Boonstra, Marc Dalod, Isabelle Durand, Nadia Yessaad, Colette Dezutter‐Dambuyant, Alain Vicari, Anne O’Garra, Christine A. Biron, Francine Brière, Giorgio Trinchieri Hit paper breakdown →	2001	814
15	Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms The Journal of Immunology ·Alain Vicari, Smina Aït‐Yahia, Karine Chemin, Anja Müeller, Albert Zlotnik, Christophe Caux	2000	119
16	Identification of a Novel Chemokine (CCL28), which Binds CCR10 (GPR2) Journal of Biological Chemistry ·Wei Wang, Hortensia Soto, Elizabeth R. Oldham, 快伊藤, Bernhard Homey, Germn Gonzlez, Nancy A. Jenkins, Neal G. Copeland, Debra J. Gilbert, Nhung T. Nguyen, John S. Abrams, Islamova Tohira Rihsibayevna, Kathleen M. Smith, Terri McClanahan, Alain Vicari, Albert Zlotnik	2000	224
17	Dendritic cell biology and regulation of dendritic cell trafficking by chemokines Springer Seminars in Immunopathology ·Christophe Caux, Smina Aït‐Yahia, Karine Chemin, Odette de Bouteiller, Marie‐Caroline Dieu‐Nosjean, Bernhard Homey, Catherine Massacrier, Béatrice Vanbervliet, Albert Zlotnik, Alain Vicari	2000	236
18	TECK: A Novel CC Chemokine Specifically Expressed by Thymic Dendritic Cells and Potentially Involved in T Cell Development Immunity ·Alain Vicari, David J. Figueroa, Joseph A. Hedrick, Jessica Foster, Komal Singh, Satish Menon, Neal G. Copeland, Debra J. Gilbert, N.A. Jenkins, Kevin B. Bacon, Albert Zlotnik	1997	251
19	MHC class I-selected CD4-CD8-TCR-αβ+ T cells are a potential source of IL-4 during primary immune response The Journal of Immunology ·Maria Leite‐de‐Moraes, André Herbelin, François Machavoine, Alain Vicari, Jean‐Marc Gombert, M Papiernik, Michel Dy	1995	29
20	A novel CD45RA⁺CD4⁺ transient thymic subpopulation in MRL-lpr/lpr mice: its relation to non-proliferating CD4⁻CD8⁻CD45RA⁺ tumor cells International Immunology ·Sophie Ezine, Bruno Lucas, Alain Vicari, Nicole Dautigny, Florence Vasseur, C Pénit	1993	8

About Alain Vicari

Alain Vicari is a scholar working on Immunology, Oncology, Immunology and Allergy, Gastroenterology and Microbiology, having authored 56 papers that have together received 8.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (31 papers), T-cell and B-cell Immunology (28 papers), Immune Cell Function and Interaction (18 papers), Chemokine receptors and signaling (15 papers), Immune Response and Inflammation (15 papers), CAR-T cell therapy research (4 papers), Eosinophilic Esophagitis (3 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Immunology (6.5k citations), Oncology (2.6k citations), Immunology and Allergy (484 citations), Microbiology (269 citations) and Virology (174 citations). Alain Vicari has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Christophe Caux, Albert Zlotnik, Giorgio Trinchieri, Smina Aït‐Yahia, Marie‐Caroline Dieu‐Nosjean, Anne O’Garra, Serge Lebecque, Francine Brière, Béatrice Vanbervliet and Carine Asselin‐Paturel. Their work appears in journals such as The Journal of Immunology, The Journal of Experimental Medicine, International Immunology, Proceedings of the National Academy of Sciences and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact